nitroblue tetrazolium has been researched along with Gammapathy, Monoclonal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Korotkiĭ, VV; Kotsaĭ, BR; Loginskiĭ, VE | 1 |
| Baklaja, R; Jelić, S; Miletić, V; Paljm, A; Rosić, D | 1 |
2 other study(ies) available for nitroblue tetrazolium and Gammapathy, Monoclonal
| Article | Year |
|---|---|
[Significance of the nitroblue tetrazolium reduction test for the diagnosis of infectious complications in patients with lymphoproliferative diseases].
Topics: Bacterial Infections; Hodgkin Disease; Humans; Leukemia, Lymphoid; Lymphoma; Lymphoproliferative Disorders; Nitroblue Tetrazolium; Oxidation-Reduction; Paraproteinemias; Tetrazolium Salts | 1978 |
[Essential IgG-IgM cryoglobulinemia, microangiopathy and transient deficiency in reduction of Nitroblue Tetrazolium (NBT) by neutrophil granulocytes].
Topics: Antibody Formation; Arteries; Blood Protein Disorders; Cryoglobulins; Humans; Immunity, Cellular; Immunoglobulin G; Immunoglobulin M; Male; Middle Aged; Neutrophils; Nitroblue Tetrazolium; Paraproteinemias; Tetrazolium Salts; Vascular Diseases | 1976 |